Navigation Links
GSI Group Inc. to Restate Financial Results for 2006
Date:3/30/2009

BEDFORD, Mass., March 30 /PRNewswire-FirstCall/ -- GSI Group Inc. (Nasdaq: GSIG), a supplier of precision technology and semiconductor systems, today announced that it has identified errors related to timing of the recognition of revenue from sales to certain customers in its Semiconductor Systems Segment during fiscal year 2006. The Audit Committee of the Board of Directors of GSI Group has concluded that the range of potential adjustments resulting from the identified errors is material to the 2006 interim and annual historical financial statements of GSI Group. As a result, the Audit Committee has determined that GSI Group's previously issued interim and annual historical financial statements for fiscal year 2006 should no longer be relied upon.

Further, GSI Group announced that substantially all amounts due from customers associated with these transactions have been paid and substantially all of the customer obligations associated with these 2006 transactions have been fulfilled. GSI Group disclosed that it does not currently expect that its cash position will be materially impacted by the correction of these accounting errors.

GSI Group also announced that its Audit Committee, with the assistance of independent legal counsel and forensic accountants, has not yet concluded its review of transactions in its Semiconductor Systems Segment and other sales transactions that contain arrangements with multiple deliverables for 2006, 2007 and 2008. The Audit Committee's review is ongoing and additional adjustments to GSI Group's historical financial statements may be required as a result of the review.

About GSI Group Inc.

GSI Group Inc. supplies precision technology to the global medical, electronics, and industrial markets and semiconductor systems. GSI Group Inc.'s common shares are listed on Nasdaq (GSIG).

Forward Looking Information

Certain statements in this release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on current expectations and assumptions that are subject to risks and uncertainties. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements. These forward-looking statements include statements regarding the qualitative and quantitative effects of the restatement, the periods covered by the restatement, the nature of the Audit Committee's review and any anticipated conclusions of GSI Group, its Audit Committee or management, and other statements that are not historical facts. These forward looking statements are subject to risks, uncertainties and changes in financial condition, unknown factors and other items described in GSI Group's annual report on Form 10-K for the fiscal year ended December 31, 2007 and the quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. Such statements are based on management's beliefs and assumptions and on information currently available to GSI Group's management. Actual results may differ materially from the preliminary expectations expressed or implied in these forward-looking statements due to various risks, uncertainties or other factors, including the outcome and results of the review by the Audit Committee and GSI Group's independent registered public accounting firm. GSI Group disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this document.

For more information contact: Sergio Edelstein, GSI Group Inc., 1-781-266-5700.


'/>"/>
SOURCE GSI Group Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Avicena Group to Present at Noble Financial Conference
2. Chrome Group to Seek Listing for Some of its Subsidiaries
3. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
4. Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy
5. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
6. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
7. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
8. ThirdBiotech Networking Group Launches
9. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
10. Reed Group Ltd. Announces Enterprise License for New Zealands Accident Compensation Corporation
11. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... , March 1, 2017  Friends, family, healthcare ... with multiple sclerosis (MS), a chronic condition affecting the ... MSWorld , MS Views and News , ... Multiple Sclerosis Foundation — have joined biotechnology company ... through the #MySupportHero initiative. During MS Awareness Month, there ...
(Date:3/1/2017)... ... 01, 2017 , ... At interpack 2017, held in Düsseldorf, ... and quality can help food and pharmaceutical manufacturers improve processes and increase competitiveness ... checkweighing to vision inspection and metal detection – will be on display, as ...
(Date:3/1/2017)... (PRWEB) , ... March 01, 2017 , ... ... Inc. will hold its annual technology show and open house, Southern Tech Fest, ... machinery from Okuma, Tsugami, Hardinge Group and Chiron and perform live metal cutting ...
(Date:2/28/2017)... ... February 28, 2017 , ... Singota Solutions announced it has ... filling injectable drug products into vials, syringes, and cartridges. , The centerpiece of ... of Singota Solutions Alisa Wright expressed the importance of this development: “Singota is ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... Feb. 8, 2017 About Voice Recognition Biometrics ... match it against a stored voiceprint template. Acoustic ... cadence, and tone are compared to distinguish between ... installation, as most PCs already have a microphone ... Voice recognition biometrics are most likely to be ...
(Date:2/8/2017)... 2017 Report Highlights ... The global synthetic-biology market reached nearly ... 2021, growing at a compound annual growth rate (CAGR) of ... the global markets for synthetic biology. - Analyses of global ... projections of compound annual growth rates (CAGRs) through 2021. - ...
Breaking Biology News(10 mins):